About Erasca, Inc. 
Erasca, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Strategic Entities
Domestic Funds
Held in 41 Schemes (15.17%)
Foreign Institutions
Held by 78 Foreign Institutions (7.04%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
(Quarterly Results - Mar 2026)
Net Profit:
-183 Million
Pharmaceuticals & Biotechnology
USD 4,653 Million (Small Cap)
NA (Loss Making)
NA
0.00%
-0.83
-35.38%
14.31






